The Shifting Evidence Landscape in the Era of COVID-19

October 13, 2020

There is extreme pressure on governments, researchers, and health care providers to deliver effective, evidence-based approaches to the prevention, detection, treatment, and management of COVID-19. The ever-evolving need for decisive action amidst a backdrop of constantly changing information about the virus is altering the evidence landscape in many ways.

Join CADTH on Oct 20, at 02:00 PM for a discussion with leading experts as they explore the ways in which COVID-19 has changed the evidence landscape paradigm, the type of evidence used to make decisions, the utility of rapid reviews to support critically important policy and clinical decisions, and the level of risk decision-makers are willing to tolerate.


Suzanne McGurn, CEO, CADTH


  • Christopher McCabe, Executive Director and CEO, Institute of Health Economics
  • Anne Hayes, Director, Research, Analysis and Evaluation Branch, Ontario Ministry of Health and Co-Chair of the Evidence Synthesis Network, and Member of the COVID-19 Advisory for Ontario Science Table
  • Nicole Mittmann, Chief Scientist and Vice-President, Evidence Standards, CADTH

To participate, please register (there is no cost). After registering, you will receive a confirmation email with information about how to join the webinar. Register here.

Share This Story!